SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-069723
Filing Date
2014-02-26
Accepted
2014-02-26 16:12:06
Documents
3
Period of Report
2014-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d680527d8k.htm 8-K 19799
2 EX-99.1 d680527dex991.htm EX-99.1 9296
3 GRAPHIC g680527logo.jpg GRAPHIC 15695
  Complete submission text file 0001193125-14-069723.txt   52066
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 14644750
SIC: 2834 Pharmaceutical Preparations